The Screening Research of NF-κB Inhibitors from Moutan Cortex Based on Bioactivity-Integrated UPLC-Q/TOF-MS

Table 1

MS/MS data in (±) ESI modes and the identification results for the bioactive compounds in Moutan Cortex (MC).

No.	RT/min	Identification results	Composition	m/z	MS/MS
1	1.71	gallic acid	C7H6O5	169.0145 [M-H]^-	125 [M-H-COO]^-
2	5.55	oxypaeoniflora	C23H28O12	495.1476 [M-H]^-	465 [M-H-CH2O]^-
					137 [M-H-C6H11O6-C10H12O3]^-
3	8.69	paeoniflorin	C23H28O11	479.1545 [M-H]^-	525 [M+HCOO]-
					449 [M-H-HCHO]^-
					327 [M-H-HCHO-C7H5O2]^-
					121 [M-H-C10H11O3-C6H11O6]^-
4	11.41	galloylpaeoniflorin	C30H32O15	631.1708 [M-H]^-	469 [M-H-C9H6O3]^-
5	15.88	benzoyloxypaeoniflorin	C30H32O13	599.1768 [M-H]-	569 [M-H-CH2O]^-
					431 [M-H-C7H5O3]^-
6	17.09	mudanpioside C	C30H32O13	599.1768 [M-H]^-	569 [M-H-CH2O]^-
					477 [M-H-C7H5O2]^-
7	18.98	paeonol	C9H10O3	167.0711 [M+H]^+	149 [M+H-H2O]^+